MA50991A - Composition ophtalmique topique comprenant de l'acide dobésilique pour le traitement de maladies du segment postérieur de l'oeil - Google Patents
Composition ophtalmique topique comprenant de l'acide dobésilique pour le traitement de maladies du segment postérieur de l'oeilInfo
- Publication number
- MA50991A MA50991A MA050991A MA50991A MA50991A MA 50991 A MA50991 A MA 50991A MA 050991 A MA050991 A MA 050991A MA 50991 A MA50991 A MA 50991A MA 50991 A MA50991 A MA 50991A
- Authority
- MA
- Morocco
- Prior art keywords
- diseases
- eye
- treatment
- composition including
- ophthalmic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382832 | 2017-12-04 | ||
| PCT/EP2018/082999 WO2019110416A1 (fr) | 2017-12-04 | 2018-11-29 | Composition ophtalmique topique comprenant de l'acide dobésilique pour le traitement de maladies du segment postérieur de l'oeil |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA50991A true MA50991A (fr) | 2020-10-14 |
| MA50991B1 MA50991B1 (fr) | 2023-03-31 |
Family
ID=60673756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA50991A MA50991B1 (fr) | 2017-12-04 | 2018-11-29 | Composition topique ophtalmique comprenent de l'acide dobesilique pour le traitement des maladies du segment postérieur de l' il |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20200390729A1 (fr) |
| EP (1) | EP3720428B1 (fr) |
| JP (1) | JP2021505554A (fr) |
| KR (1) | KR20200096569A (fr) |
| CN (1) | CN111542316A (fr) |
| AU (1) | AU2018378981A1 (fr) |
| BR (1) | BR112020011160A2 (fr) |
| CA (1) | CA3083835A1 (fr) |
| CL (1) | CL2020001426A1 (fr) |
| DK (1) | DK3720428T3 (fr) |
| ES (1) | ES2941036T3 (fr) |
| FI (1) | FI3720428T3 (fr) |
| HR (1) | HRP20230319T1 (fr) |
| HU (1) | HUE061852T2 (fr) |
| MA (1) | MA50991B1 (fr) |
| MX (1) | MX2020005809A (fr) |
| PH (1) | PH12020550722A1 (fr) |
| PL (1) | PL3720428T3 (fr) |
| PT (1) | PT3720428T (fr) |
| SG (1) | SG11202004940VA (fr) |
| SI (1) | SI3720428T1 (fr) |
| WO (1) | WO2019110416A1 (fr) |
| ZA (1) | ZA202003944B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117643573B (zh) * | 2024-01-29 | 2024-05-03 | 天津医科大学眼科医院 | 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE51421B1 (en) * | 1980-08-01 | 1986-12-24 | Smith & Nephew Ass | Ophthalmic compositions containing triamterene |
| US9198886B2 (en) * | 2006-08-16 | 2015-12-01 | Pedro Cuevas Sánchez | Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| EA201491062A1 (ru) * | 2011-11-30 | 2014-10-30 | Ксиджен Инфлэммэйшн Лтд. | Применение обладающих способностью проникать в клетку пептидных ингибиторов пути трансдукции сигнала jnk для лечения синдрома сухости глаз |
| PT2777699T (pt) * | 2012-02-02 | 2017-07-07 | Invesfovea S L | Dietilamina-2,5-di-hidroxibenzenossulfonato para o tratamento de degeneração macular relacionada com a idade |
| HUE040487T2 (hu) * | 2012-03-05 | 2019-03-28 | Univ Wayne State | Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások |
| CA2871528A1 (fr) * | 2012-04-24 | 2013-10-31 | Thrombogenics N.V. | Anticorps anti-pdgf-c |
| EP2875811A1 (fr) * | 2013-11-26 | 2015-05-27 | Luis Antonio Outeirino Miguez | Utilisation de dobésilate pour le traitment d'hémorragie oculaire |
-
2018
- 2018-11-29 CN CN201880082202.1A patent/CN111542316A/zh active Pending
- 2018-11-29 SG SG11202004940VA patent/SG11202004940VA/en unknown
- 2018-11-29 AU AU2018378981A patent/AU2018378981A1/en active Pending
- 2018-11-29 CA CA3083835A patent/CA3083835A1/fr active Pending
- 2018-11-29 ES ES18811023T patent/ES2941036T3/es active Active
- 2018-11-29 HU HUE18811023A patent/HUE061852T2/hu unknown
- 2018-11-29 KR KR1020207018983A patent/KR20200096569A/ko not_active Application Discontinuation
- 2018-11-29 JP JP2020529733A patent/JP2021505554A/ja active Pending
- 2018-11-29 BR BR112020011160-0A patent/BR112020011160A2/pt unknown
- 2018-11-29 HR HRP20230319TT patent/HRP20230319T1/hr unknown
- 2018-11-29 SI SI201830869T patent/SI3720428T1/sl unknown
- 2018-11-29 WO PCT/EP2018/082999 patent/WO2019110416A1/fr unknown
- 2018-11-29 PL PL18811023.3T patent/PL3720428T3/pl unknown
- 2018-11-29 DK DK18811023.3T patent/DK3720428T3/da active
- 2018-11-29 FI FIEP18811023.3T patent/FI3720428T3/fi active
- 2018-11-29 PT PT188110233T patent/PT3720428T/pt unknown
- 2018-11-29 EP EP18811023.3A patent/EP3720428B1/fr active Active
- 2018-11-29 MX MX2020005809A patent/MX2020005809A/es unknown
- 2018-11-29 MA MA50991A patent/MA50991B1/fr unknown
- 2018-11-29 US US16/770,027 patent/US20200390729A1/en active Pending
-
2020
- 2020-05-27 PH PH12020550722A patent/PH12020550722A1/en unknown
- 2020-05-28 CL CL2020001426A patent/CL2020001426A1/es unknown
- 2020-06-29 ZA ZA2020/03944A patent/ZA202003944B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3720428A1 (fr) | 2020-10-14 |
| HUE061852T2 (hu) | 2023-08-28 |
| BR112020011160A2 (pt) | 2020-11-17 |
| PT3720428T (pt) | 2023-04-03 |
| MX2020005809A (es) | 2020-08-20 |
| SI3720428T1 (sl) | 2023-05-31 |
| ES2941036T3 (es) | 2023-05-16 |
| KR20200096569A (ko) | 2020-08-12 |
| ZA202003944B (en) | 2022-12-21 |
| EP3720428B1 (fr) | 2023-01-11 |
| PH12020550722A1 (en) | 2021-02-15 |
| AU2018378981A1 (en) | 2020-07-16 |
| SG11202004940VA (en) | 2020-06-29 |
| HRP20230319T1 (hr) | 2023-05-12 |
| PL3720428T3 (pl) | 2023-05-08 |
| CN111542316A (zh) | 2020-08-14 |
| WO2019110416A1 (fr) | 2019-06-13 |
| DK3720428T3 (da) | 2023-03-20 |
| MA50991B1 (fr) | 2023-03-31 |
| JP2021505554A (ja) | 2021-02-18 |
| FI3720428T3 (fi) | 2023-03-30 |
| CA3083835A1 (fr) | 2019-06-13 |
| CL2020001426A1 (es) | 2020-11-06 |
| US20200390729A1 (en) | 2020-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019007586A (es) | Composiciones que comprenden tacrolimus para el tratamiento de enfermedades inflamatorias intraoculares. | |
| MA49664A (fr) | Combinaisons d'un dérivé de 4-pyrimidinesulfamide avec des principes actifs pour le traitement de maladies liées à l'endothéline | |
| MA51916A (fr) | Compositions pour le traitement de la dégénérescence maculaire liée à l'âge humide | |
| MX2016014634A (es) | Compuestos para el tratamiento de enfermedades y trastornos oftalmicos. | |
| MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
| MA50763A (fr) | Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires | |
| MA55325A (fr) | Composés pour le traitement de maladies pd-l1 | |
| PH12019501902A1 (en) | Ocular formulations for drug-delivery to the posterior segment of the eye | |
| MA44737A (fr) | Compositions pour le traitement de troubles liés à l'hyperkératose | |
| EA201992607A1 (ru) | Твердые формы берберина урсодезоксихолата, их композиции и способы | |
| IL281773A (en) | Eye preparation for the treatment of dry eye disease | |
| MA54077A (fr) | Polythérapie pour le traitement de maladies hématologiques | |
| MA50441A (fr) | Nouvelle association d'agents actifs pour le traitement de pneumopathies interstitielles fibrosantes progressives (pf-ild) | |
| IL273531A (en) | Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases | |
| MA55872A (fr) | Anticorps anti-sema3a et leurs utilisations pour le traitement de maladies oculaires | |
| MA43828A (fr) | Agents thérapeutiques pour maladies neurodégénératives | |
| MA52873A (fr) | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies | |
| MX355770B (es) | Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico. | |
| MA54792A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
| MA54522A (fr) | Composition pharmaceutique pour le traitement de l'hypertension artérielle pulmonaire | |
| MA50991A (fr) | Composition ophtalmique topique comprenant de l'acide dobésilique pour le traitement de maladies du segment postérieur de l'oeil | |
| MA56220A (fr) | Formulations oculaires permettant l'administration de médicament et la protection du segment antérieur de l'oeil | |
| FR3019465B1 (fr) | Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen | |
| MA41142A (fr) | Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement | |
| IL282898A (en) | Ophthalmic compounds and methods for treating skin and eye diseases |